Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CRLF2 antibody (AA 20-233) (APC)

This Goat Polyclonal antibody specifically detects CRLF2 in FACS. It exhibits reactivity toward Mouse.
Catalog No. ABIN2374810

Quick Overview for CRLF2 antibody (AA 20-233) (APC) (ABIN2374810)

Target

See all CRLF2 Antibodies
CRLF2 (Cytokine Receptor-Like Factor 2 (CRLF2))

Reactivity

  • 41
  • 24
  • 19
Mouse

Host

  • 50
  • 13
  • 2
Goat

Clonality

  • 52
  • 13
Polyclonal

Conjugate

  • 24
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CRLF2 antibody is conjugated to APC

Application

  • 38
  • 27
  • 26
  • 16
  • 9
  • 6
  • 5
  • 4
  • 4
  • 2
  • 1
  • 1
Flow Cytometry (FACS)
  • Binding Specificity

    • 15
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 20-233

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    Thymic Stromal Lymphopoietin Receptor (TSLP R, CRL2, CRLF2, CRLM-2, CRLM2, Cytokine Receptor-like Module 2, PCOR1) (APC)

    Purification

    Purified by Protein A or G affinity chromatography.

    Immunogen

    Recombinant protein corresponding to aa20-233 from mouse TSLP R, NS0-derived.

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, 0.5 % BSA, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    4°C ,Do Not Freeze
  • Target

    CRLF2 (Cytokine Receptor-Like Factor 2 (CRLF2))

    Alternative Name

    Thymic Stromal Lymphopoietin Receptor
You are here:
Chat with us!